Semaglutide Treatment in Type 1 Diabetes

NCT06909006 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

122

Enrollment

OTHER

Sponsor class

Conditions

Obesity in Diabetes
Obesity/Therapy
Type 1 Diabetes Mellitus (T1DM)
Insulin Sensitivity/Resistance
Semaglutide
Lipidomics
Metabolomics
Weight Loss
Glycemic Control for Diabetes Mellitus

Interventions

DRUG: Semaglutide 2.4mg
DRUG: Semaglutide placebo

Sponsor

Nordsjaellands Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]